Literature DB >> 2554924

Dideoxycytidine permeation and salvage by mouse leukemia cells and human erythrocytes.

P G Plagemann1, C Woffendin.   

Abstract

Transmembrane equilibration of dideoxycytidine (ddCyd) in P388 mouse leukemia cells and human erythrocytes was only 1% as rapid as that of uridine and 2'-deoxycytidine which is mediated by the facilitated nucleoside transporter of these cells. ddCyd entry was nonsaturable up to a concentration of 1 mM but was partially inhibited by dipyridamole, nitrobenzylthioinosine and nucleosides, but not by nucleobases. Thus, entry was partly (70-80%) mediated, though very inefficiently, by the nucleoside carrier. Intracellular phosphorylation of ddCyd in P388 cells was also very inefficient compared to that of 2'-deoxycytidine and uridine and not rate limited by its slow entry into the cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554924     DOI: 10.1016/0006-2952(89)90116-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Zalcitabine population pharmacokinetics: application of radioimmunoassay.

Authors:  J M Adams; M J Shelton; R G Hewitt; M DeRemer; R DiFrancesco; T H Grasela; G D Morse
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 2.  Zalcitabine. Clinical pharmacokinetics and efficacy.

Authors:  D Devineni; J M Gallo
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

3.  Differential inhibition of 2'-deoxycytidine salvage as a possible mechanism for potentiation of the anti-human immunodeficiency virus activity of 2',3'-dideoxycytidine by dipyridamole.

Authors:  S S Patel; J Szebeni; L M Wahl; J N Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 4.  Comparative pharmacokinetics of antiviral nucleoside analogues.

Authors:  G D Morse; M J Shelton; A M O'Donnell
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.